Haneen A Al-Mazroua

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Molecular Docking

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Partha Saradhi Tallapalli, Yennam Dastagiri Reddy, Deepak A Yaraguppi, Surya Prabha Matangi, Ranadheer Reddy Challa, Bhaskar Vallamkonda, Sheikh Fayaz Ahmad, Haneen A Al-Mazroua, Mithun Rudrapal, D S N B K Prasanth, Praveen Kumar Pasala
In Silico and In Vivo Studies of β-Sitosterol Nanoparticles as a Potential Therapy for Isoprenaline-Induced Cognitive Impairment in Myocardial Infarction, Targeting Myeloperoxidase. Pharmaceuticals (Basel, Switzerland) 17 (8) (2024)
Partha Saradhi Tallapalli, Yennam Dastagiri Reddy, Deepak A Yaraguppi, Surya Prabha Matangi, Ranadheer Reddy Challa, Bhaskar Vallamkonda, Sheikh Fayaz Ahmad, Haneen A Al-Mazroua, Mithun Rudrapal, D S N B K Prasanth, Praveen Kumar Pasala
In Silico and In Vivo Studies of β-Sitosterol Nanoparticles as a Potential Therapy for Isoprenaline-Induced Cognitive Impairment in Myocardial Infarction, Targeting Myeloperoxidase. Pharmaceuticals (Basel, Switzerland) 17 (8) (2024)
Abdullah A Aldossari, Mohammed A Assiri, Mushtaq Ahmad Ansari, Ahmed Nadeem, Sabry M Attia, Saleh A Bakheet, Thamer H Albekairi, Hatun A Alomar, Haneen A Al-Mazroua, Taghreed N Almanaa, Mohammed A Al-Hamamah, Mohammad Y Alwetaid, Sheikh Fayaz Ahmad
Histamine H4 Receptor Antagonist Ameliorates the Progression of Experimental Autoimmune Encephalomyelitis via Regulation of T-Cell Imbalance. International journal of molecular sciences 24 (20) (2023)